Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash Sells 15,011 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash sold 15,011 shares of the firm’s stock in a transaction on Monday, January 13th. The shares were sold at an average price of $0.81, for a total transaction of $12,158.91. Following the sale, the senior vice president now owns 222,291 shares in the company, valued at approximately $180,055.71. This represents a 6.33 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Marc Nash also recently made the following trade(s):

• On Tuesday, January 7th, Marc Nash sold 720 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $928.80.
• On Friday, November 15th, Marc Nash sold 1,375 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total value of $1,100.00.

Outset Medical Stock Down 12.2 %

Shares of NASDAQ OM opened at $0.81 on Tuesday. The firm has a market cap of $42.44 million, a price-to-earnings ratio of -0.29 and a beta of 2.05. The company’s 50-day simple moving average is $1.01 and its 200-day simple moving average is $1.41. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 52-week low of $0.44 and a 52-week high of $5.22.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reissued a “sector perform” rating and issued a $3.00 price objective on shares of Outset Medical in a report on Tuesday, January 7th.

Institutional Investors Weigh In On Outset Medical

Several institutional investors have recently bought and sold shares of OM. National Bank of Canada FI lifted its position in shares of Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after acquiring an additional 23,164 shares in the last quarter. Huntington National Bank raised its stake in Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the last quarter. Vanguard Personalized Indexing Management LLC purchased a new position in Outset Medical in the 2nd quarter valued at $49,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Outset Medical during the 2nd quarter worth $259,000. Finally, Squarepoint Ops LLC grew its holdings in shares of Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after buying an additional 34,187 shares in the last quarter.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.